Skip to main content

Silexion Therapeutics Corp 10-Q for FY2024 Q2

Silexion Therapeutics Corp (SLXN)

10-Q 2024-08-29 For: 2024-06-30
View Original
Added on April 06, 2026

About this 10-Q

Silexion Therapeutics Corp filed this 10-Q on August 29, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).

Headline figures

Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$1.49M
compared with a net loss of $1.88M a year earlier
Diluted EPS
$5.87
down 10.2% from $6.54 a year earlier